DZ Bank Call 200 ESL 20.09.2024/ DE000DJ52R04 /
25/06/2024 9:04:20 | Diferencia-0.17 | Bid13:56:27 | Ask13:56:27 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
1.48EUR | -10.30% | 1.51 Volumen de oferta: 22,000 |
1.53 Tamaño/ Volumen/ Formato de Ask: 22,000 |
ESSILORLUXO. INH. EO... | 200.00 EUR | 20/09/2024 | Call |
GlobeNewswire
14:18
Frontline Education Releases Research Brief Exploring K-12 Educators’ Perspectives on AI Adoption an...
GlobeNewswire
14:15
Ingersoll Rand Names Scott Watson as Leader for Life Science Technologies Platform
GlobeNewswire
14:15
Prima at Paseo South Gulch Introduces Electric Car Sharing Program for Residents through Envoy Techn...
GlobeNewswire
14:07
Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor
GlobeNewswire
14:05
N2OFFAnnounces Breakthrough in Reducing N₂O Emissions with Innovative Bacterial Technology in Corn C...
GlobeNewswire
14:05
Tevogen Bio Announces Publication of Positive Phase I Clinical Trial Results for TVGN 489 in Blood A...
GlobeNewswire
14:00
Data Supporting Nanox.AI Cardiac Solution to Be Presented at 19th Annual Meeting of the Society of C...
GlobeNewswire
14:00
Lightbridge Welcomes Passage of the ADVANCE Act, Landmark Legislation to Expedite Commercial Deploym...
GlobeNewswire
14:00
AFCEA International Proudly Announces New Board Chair, Vice Chair, Executive Committee and Board of ...
GlobeNewswire
14:00
Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and Canada
Newsfile Corp
14:00
Teako Minerals Successfully Concludes Sandefjord Rare Earth Element Program and Mobilizes Field Crew...
GlobeNewswire
14:00
LOBO EV Strengthens Partnership with a Well-Established Brazilian Distributor Following Successful O...
GlobeNewswire
14:00
Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epine...
GlobeNewswire
14:00
Treasure Global Inc Announces New Leadership Team to Drive New Vision and Strategy Forward
GlobeNewswire
14:00
BioVie Presents Protocol Design of Upcoming SUNRISE-PD Phase 2 Trial of Bezisterim in Patients with ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página